Cargando…

First Outcome of MDR-TB among Co-Infected HIV/TB Patients from South-West Iran

BACKGROUND: Tuberculosis (TB) is the leading cause of mortality among human immunodeficiency virus (HIV) patients and the majority of them occur in developing countries. The aims of the present study were to determine the frequency of HIV/TB co-infection and other probable associated factors. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motamedifar, Mohammad, Ebrahim-Saraie, Hadi Sedigh, Abadi, Ali Reza Hassan, Moghadam, Mahboube Nakhzari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499594/ https://www.ncbi.nlm.nih.gov/pubmed/26175780 http://dx.doi.org/10.4046/trd.2015.78.3.253

Ejemplares similares

Emergence of SCCmec Type I Obtained From Clinical Samples in Shiraz Teaching Hospitals, South-West of Iran
por: Ebrahim-Saraie, Hadi Sedigh, et al.
Publicado: (2015)

High Incidence of Virulence Factors Among Clinical Enterococcus faecalis Isolates in Southwestern Iran
por: Heidari, Hamid, et al.
Publicado: (2017)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

Gonorrhea and syphilis co-infection and related risk factors in HIV patients from Shiraz, South of Iran
por: Ghassabi, Farzaneh, et al.
Publicado: (2018)

Emergence of Multidrug Resistance and Metallo-beta-lactamase Producing Acinetobacter baumannii Isolated from Patients in Shiraz, Iran
por: Moghadam, MN, et al.
Publicado: (2016)

The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran
por: Yousefi-Avarvand, Arshid, et al.
Publicado: (2015)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Prevalence of antibiotic resistance and integrons, sul and Smqnr genes in clinical isolates of Stenotrophomonas maltophilia from a tertiary care hospital in Southwest Iran
por: Ebrahim-Saraie, Hadi Sedigh, et al.
Publicado: (2019)

Why has MDR-TB prevalence increased in Iran?
por: Heidary, Mohsen, et al.
Publicado: (2016)

Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients
por: Rezaei, Esmaeil, et al.
Publicado: (2016)

Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant Staphylococcus aureus Strains
por: Hadadi, Mahtab, et al.
Publicado: (2018)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus aureus (MRSA) Strains
por: Hoseini Alfatemi, Seyedeh Mahsan, et al.
Publicado: (2014)

Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?
por: Burugina Nagaraja, Sharath, et al.
Publicado: (2011)

Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran [Response to letter]
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Phenotypic and genotypic characterization of macrolide, lincosamide and streptogramin B resistance among clinical isolates of staphylococci in southwest of Iran
por: Khashei, Reza, et al.
Publicado: (2018)

Sudden unexplained death in a patient with HIV and MDR-TB
por: Boxall, E, et al.
Publicado: (2010)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010)

The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

International Spread of MDR TB from Tugela Ferry, South Africa
por: Cooke, Graham S., et al.
Publicado: (2011)

Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile
por: Heidari, Hamid, et al.
Publicado: (2019)

The Profile of the Patients with Double Infection HIV and TB in South West of Romania
por: STOICA (CĂLĂRAŞU), CRISTINA, et al.
Publicado: (2021)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

Correction: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

SEVERITY OF TB CLASSIFIED BY MODIFIED BANDIM TB SCORING ASSOCIATES WITH THE SPECIFIC SEQUENCE OF ESXA GENES IN MDR-TB PATIENTS
por: Dewi, Desak Nyoman Surya Suameitria, et al.
Publicado: (2020)

Incidence of TB and HIV in Prospectively Followed Household Contacts of TB Index Patients in South Africa
por: van Schalkwyk, Cari, et al.
Publicado: (2014)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
por: Hafkin, Jeffrey, et al.
Publicado: (2017)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes
por: Loveday, Marian, et al.
Publicado: (2014)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jma9e7a3oja281pmfhf2mictj3